News brief
On 2026-09-14, according to Xiniu Data, Yuanshi Technology completed equity financing for an undisclosed amount. Investors were Monolith VC II SPV Limited, Shanghai Innovation Gongchangzhichuang Venture Capital Partnership (Limited Partnership), Shanghai Aochuangxiandao Venture Capital Partnership (Limited Partnership), Shanghai Weilaiyongxianqiye Consulting Partnership (Limited Partnership), Shanghai Yanyuanjingchun Venture Capital Partnership (Limited Partnership). The company is a developer of second-generation AI drug discovery technology.
Connected profiles
Explore
Sources · 0Sources & provenance
English text is maintained separately from the original record. Consult the original source before citing a fact.
No source links are available for this profile.
Original source text
Names may use phonetic renderings when no English name is supplied. The original wording is retained below.
2026年9月14日，据烯牛数据报道，元示科技完成股权投资融资，金额未披露。投资方为Monolith VC II SPV Limited，上海创新工场智创创业投资合伙企业（有限合伙），上海奥创先导创业投资合伙企业（有限合伙），上海未来涌现企业咨询合伙企业（有限合伙），上海燕缘镜春创业投资合伙企业（有限合伙）。该公司为第二代人工智能制药技术研发商。